Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Min Kyoung | - |
dc.contributor.author | Chon, Seung Joo | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Yun, Bo Hyon | - |
dc.contributor.author | Cho, SiHyun | - |
dc.contributor.author | Choi, Young Sik | - |
dc.contributor.author | Lee, Byung Seok | - |
dc.contributor.author | Seo, Seok Kyo | - |
dc.date.available | 2020-02-27T12:41:33Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-01 | - |
dc.identifier.issn | 1933-7191 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/4184 | - |
dc.description.abstract | Objective: The aim of this study was to evaluate the effectiveness of postoperative levonorgestrel-releasing intrauterine system (LNG-IUS) insertion after gonadotropin-releasing hormone agonist (GnRH-a) treatment for preventing endometriotic cyst recurrence. Study Design: The LNG-IUS was applied to 28 women who had undergone surgery for endometriosis followed by 6 cycles of GnRH-a treatment. Clinical characteristics, endometriosis recurrence, and adverse effects were analyzed. Student t test was performed for analysis. Results: Before surgery, 20 (71.4%) patients had dysmenorrhea, and the mean pain score (visual analog scale [VAS]) was 4.26. The numbers of women diagnosed with stage III endometriosis and stage IV endometriosis were 15 (53.6%) and 13 (46.4%), respectively, according to the revised American Fertility Society scoring system. The mean cancer antigen 125 levels and VAS scores were significantly lower after treatment than before treatment (11.61 vs 75.66 U/mL, P < .0001 and 0.50 vs 4.26 U/mL, P < .0001, respectively). Of the 28 patients, 13 (46.4%) simultaneously had adenomyosis, and 2 (7.1%) underwent LNG-IUS removal because of unresolved vaginal bleeding and dysmenorrhea. Recurrence was noted in 2 (7.1%) women. Conclusion: Postoperative LNG-IUS insertion after GnRH-a treatment is an effective approach for preventing endometriotic cyst recurrence, especially in women who do not desire to conceive. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS INC | - |
dc.relation.isPartOf | REPRODUCTIVE SCIENCES | - |
dc.subject | ORAL-CONTRACEPTIVE USE | - |
dc.subject | STAGE-III-IV | - |
dc.subject | LAPAROSCOPIC EXCISION | - |
dc.subject | OVARIAN ENDOMETRIOMA | - |
dc.subject | CONSERVATIVE SURGERY | - |
dc.subject | PELVIC PAIN | - |
dc.subject | THERAPY | - |
dc.subject | WOMEN | - |
dc.subject | RISK | - |
dc.subject | MANAGEMENT | - |
dc.title | Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000417331400006 | - |
dc.identifier.doi | 10.1177/1933719117718274 | - |
dc.identifier.bibliographicCitation | REPRODUCTIVE SCIENCES, v.25, no.1, pp.39 - 43 | - |
dc.identifier.scopusid | 2-s2.0-85038021222 | - |
dc.citation.endPage | 43 | - |
dc.citation.startPage | 39 | - |
dc.citation.title | REPRODUCTIVE SCIENCES | - |
dc.citation.volume | 25 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Chon, Seung Joo | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | endometriosis | - |
dc.subject.keywordAuthor | levonorgestrel-releasing intrauterine system | - |
dc.subject.keywordAuthor | gonadotropin-releasing hormone agonist | - |
dc.subject.keywordAuthor | endometrioma recurrence | - |
dc.subject.keywordPlus | ORAL-CONTRACEPTIVE USE | - |
dc.subject.keywordPlus | STAGE-III-IV | - |
dc.subject.keywordPlus | LAPAROSCOPIC EXCISION | - |
dc.subject.keywordPlus | OVARIAN ENDOMETRIOMA | - |
dc.subject.keywordPlus | CONSERVATIVE SURGERY | - |
dc.subject.keywordPlus | PELVIC PAIN | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalResearchArea | Reproductive Biology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Reproductive Biology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.